top of page
Longevity Biomedical, Inc. and FutureTech II Acquisition Corp. Announce Business Combination
September 20, 2024
Longevity Biomedical, Inc. and FutureTech II Acquisition Corp. Announce Business Combination to Create Nasdaq-Listed Biopharmaceutical Company Focused on Advancing New Technologies to Promote Human Health and Longevity
FutureTech II Acquisition Corp. Announces the Separate Trading
April 08, 2022
FutureTech II Acquisition Corp. Announces the Separate Trading of its Class A Common Stock and Warrants
FutureTech II Acquisition Corp. Announces Closing
Feburary 18, 2022
FutureTech II Acquisition Corp. Announces Closing of Initial Public Offering and Exercise of Full Over-Allotment Option
bottom of page